Signature of circulating microRNAs in osteoarthritis.
暂无分享,去创建一个
Georg Schett | Stefan Sesselmann | Manuel Mayr | Arnd Kleyer | Georg Egger | Johann Willeit | Annamaria Iagnocco | Kolja Gelse | Bernd Swoboda | M. Mayr | A. Iagnocco | A. Zampetaki | S. Kiechl | J. Willeit | B. Swoboda | G. Schett | P. Santer | K. Gelse | G. Egger | J. Distler | C. Perricone | Jörg H W Distler | Carlo Perricone | N. Lin | Stefan Kiechl | Sarah R Langley | C. Beyer | A. Distler | A. Kleyer | Anna Zampetaki | Peter Santer | Christian Beyer | Alfiya Distler | Andreas Niemeier | Neng-Yu Lin | Rolando Lorenzini | S. Sesselmann | A. Niemeier | S. Langley | R. Lorenzini
[1] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[2] J. Reginster,et al. The prevalence and burden of arthritis. , 2002, Rheumatology.
[3] S. Goldring,et al. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis , 2010, Annals of the New York Academy of Sciences.
[4] S. Takada,et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. , 2010, Genes & development.
[5] John D. Storey. A direct approach to false discovery rates , 2002 .
[6] E. Schipani,et al. MicroRNA-140 and the silencing of osteoarthritis. , 2010, Genes & development.
[7] S. Kiechl,et al. Vascular cell adhesion molecule 1 as a predictor of severe osteoarthritis of the hip and knee joints. , 2009, Arthritis and rheumatism.
[8] M. Goldring,et al. Epigenomic and microRNA-mediated regulation in cartilage development, homeostasis, and osteoarthritis. , 2012, Trends in molecular medicine.
[9] D. Schwartz,et al. Toll-like receptor 4 polymorphisms and atherogenesis. , 2002, The New England journal of medicine.
[10] R. Moskowitz,et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.
[11] T D Cooke,et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. , 1991, Arthritis and rheumatism.
[12] I. Clark,et al. Review: the role of microRNAs in osteoarthritis and chondrogenesis. , 2013, Arthritis and rheumatism.
[13] J. Kroin,et al. MicroRNA-146a is linked to pain-related pathophysiology of osteoarthritis. , 2011, Gene.
[14] T. Mimori,et al. Comprehensive microRNA Analysis Identifies miR-24 and miR-125a-5p as Plasma Biomarkers for Rheumatoid Arthritis , 2013, PloS one.
[15] S. Gabriel,et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. , 2008, Arthritis and rheumatism.
[16] S. Miyaki,et al. Expression of MicroRNA-146a in osteoarthritis cartilage. , 2009, Arthritis and rheumatism.
[17] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature reviews genetics.
[18] Konstantinos N. Malizos,et al. Integrative MicroRNA and Proteomic Approaches Identify Novel Osteoarthritis Genes and Their Collaborative Metabolic and Inflammatory Networks , 2008, PloS one.
[19] M. Mayr,et al. Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes , 2010, Circulation research.
[20] Yoshio Kato,et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. , 2009, Arthritis and rheumatism.
[21] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[22] M. Esteller. Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.
[23] H. Melhus. Soluble RANKL and risk of nontraumatic fracture. , 2004, JAMA.
[24] P. Wolf,et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. , 1994, American journal of public health.
[25] G. Calin,et al. MicroRNAs in body fluids—the mix of hormones and biomarkers , 2011, Nature Reviews Clinical Oncology.
[26] W. Poewe,et al. Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease , 2004, Circulation.
[27] W. Murphy,et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. , 1990, Arthritis and rheumatism.
[28] D. Patra,et al. Recent advances in biomarkers in osteoarthritis , 2011, Current opinion in rheumatology.
[29] L. Hood,et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury , 2009, Proceedings of the National Academy of Sciences.
[30] Hugh S Markus,et al. Circulating MicroRNAs as Novel Biomarkers for Platelet Activation , 2013, Circulation research.
[31] D J Hunter,et al. The diagnostic performance of MRI in osteoarthritis: a systematic review and meta-analysis. , 2012, Osteoarthritis and cartilage.
[32] Qingbo Xu,et al. Soluble Receptor Activator of Nuclear Factor-&kgr;B Ligand and Risk for Cardiovascular Disease , 2007, Circulation.
[33] Takashi Nakamura,et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis , 2010, Arthritis research & therapy.
[34] F. Kronenberg,et al. Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus , 2013, Nature Medicine.